Lymphoid enhancer-binding factor 1 (LEF1): a reliable immunohistochemical predictive marker for WNT-activated medulloblastoma

Diffuse LEF1 immunostaining is a reliable and faster method for identifying WNT-activated molecular group of MB.

Authors

Institutions

Publication Details

Journal
Child s Nervous System
Published
2025-06-17
DOI
https://doi.org/10.1007/s00381-025-06872-8
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lymphoid enhancer-binding factor 1 (LEF1): a reliable immunohistochemical predictive marker for WNT-activated medulloblastoma

Manali Ranade, Tejpal Gupta, Prakash Shetty, Sridhar Epari et al.
Child s Nervous System
Glioma Diagnosis and Treatment
article

Lymphoid enhancer-binding factor 1 (LEF1): a reliable immunohistochemical predictive marker for WNT-activated medulloblastoma

Manali Ranade, Tejpal Gupta, Prakash Shetty, Sridhar Epari, Mamta Gurav, Girish Chinnaswamy, Maya Prasad, Ayushi Sahay
article en

Abstract

Diffuse LEF1 immunostaining is a reliable and faster method for identifying WNT-activated molecular group of MB.

Child s Nervous SystemVol. 41(1)
Homi Bhabha National Institute (IN)
Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer
Zero hunger
Openalex Percentile: Top 80%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.